Render Target: STATIC
Render Timestamp: 2024-10-30T09:53:06.891Z
Commit: 23cb9f61fe67e1e9093fd644a533c4ff516a6463
XML generation date: 2024-08-01 15:28:48.398
Product last modified at: 2024-10-10T14:15:11.648Z
1% for the planet logo
PDP - Template Name: Polyclonal Antibody
PDP - Template ID: *******59c6464

SP3 Antibody #94080

Filter:
  • WB
  • IP

    Supporting Data

    REACTIVITY H M R Mk
    SENSITIVITY Endogenous
    MW (kDa) 73, 75, 115, 120
    SOURCE Rabbit
    Application Key:
    • WB-Western Blotting 
    • IP-Immunoprecipitation 
    Species Cross-Reactivity Key:
    • H-Human 
    • M-Mouse 
    • R-Rat 
    • Mk-Monkey 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunoprecipitation 1:50

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    SP3 Antibody recognizes endogenous levels of total SP3 protein. The antigenic peptide sequence is 100% conserved among the 6 isoforms of SP3 reported in Uniprot. This includes splice variants and isoforms generated by alternative translation initiation.

    Species Reactivity:

    Human, Mouse, Rat, Monkey

    Source / Purification

    Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Asp760 of human SP3 protein. Antibodies are purified by peptide affinity chromatography.

    Background

    SP3 (Specificity protein 3, Transcription factor Sp3) is a member of the Specificity Protein/Krüppel-like Factor (SP/KLF) family of DNA-binding transcription factors, which play a variety of important roles in cell function and homeostasis (1). There are nine known SP transcription factors (SP1-9); each contains a C2H2 zinc finger domain responsible for high affinity binding to GC-rich motifs that enables the activation or repression of target gene expression (2). SP1-4 contain a functional transactivation (TAD) in their amino terminus, which is notably absent from SP5-9. Despite nearly ubiquitous expression of SP transcription factors across most normal cells and tissues, research studies have identified links between expression levels and disease. It was shown, for example, that combined overexpression of v-Myc and SP1/SP3 led to oncogenic transformation of fibroblasts (3). Increased levels of SP transcription factors have likewise been reported in various tumor cells (2), while SP1, SP3, and SP4 were all reported to bind the VEGFR promoter and increase VEGF receptor expression in pancreatic cancer cells (4). The latter observation suggests that SP transcription factors may promote tumor cell growth through multiple mechanisms, including enhancing tumor angiogenesis, providing a potential avenue to therapeutic intervention.
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    XP is a registered trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.